期刊文献+

1000例孕妇孕中期唐氏筛查检测分析 被引量:5

Screening analysis on pregnant women with Down’s syndrome (Report of 1 000 cases)
下载PDF
导出
摘要 目的探讨孕中期唐氏筛查检测的临床意义。方法应用时间分辨免疫荧光法对1 000例孕14~21周妊娠妇女进行血清甲胎蛋白和游离β绒毛膜促性腺激素水平检测,将被测的孕妇血清标记物的数值结合孕妇的年龄、体重、孕周、种族、既往病史等因素输入到筛查软件中进行综合分析,得出妊娠唐氏筛查结果。结果 1 000例孕妇中,唐氏综合征筛查高风险22例,占筛查总数的2.2%,唐氏筛查阳性病例行羊水穿刺术,发现21-三体综合征1例,占阳性筛查病例的4.55%;18-三体综合征4例,占筛查总数的0.4%;神经管缺损高风险2例,占筛查总数的0.2%;预产期年龄>35岁高风险12例,占筛查总数的1.2%。结论孕中期进行血清标记物甲胎蛋白和游离β绒毛膜促性腺激素水平检测是预测异常胎儿和不良妊娠结局的有效指标,是降低出生缺陷率的有效手段,同时结合羊水或胎血、B超等其他产前筛查技术可提高产前筛查效果。 Objective To investigate the clinical value of second trimester Down's syndrome screening. Methods The level of serum AFP and free-β-hCG of 1 000 pregnant women(14-21 weeks)were detected by time-distinguished fluorescence immunoassay. The value of serum markers combined with the maternal age, body weight, gestational age, race, past medical history and other factors were taken into account to conduct a comprehensive analysis by the screening software. Results In 1 000 cases of pregnant women, 22 cases were considered as high risk of Down's syndrome, thereby the positive rate was 2.2%. All the positive cases of Down's syndrome screening received amniocentesis, 1 case of which was Down's syndrome, accounting for 4.55%; 4 cases were 18-trisomy, accounting for 0.4% of all the cases; 2 cases were of high risk of neural tube defect, accounting for 0.2% of all the cases; 12 cases of the pregnant women aged 〉35 year-old were of high risk, accounting for 1.2% of all the cases. Conclusion Maternal serum AFP and free-β-hCG level in second trimester are effective indicators for predicting abnormal fetal and adverse pregnancy outcomes. It's an effective way to reduce the rate of congenital defect. Combining the detection of maternal serum AFP and free-β-HCG level with amniotic fluid or umbilical cord blood detection and B-ultrasonic examination may improve the effective rate of prenatal screening. Therefore, in order to give a good prenatal care and improve the quality of newborn babies it is necessary to popularize prenatal detection and make more pregnant women realize the importance of prenatal screening.
出处 《医学研究与教育》 CAS 2013年第3期43-46,共4页 Medical Research and Education
关键词 产前筛查 唐氏综合征 18-三体综合征 prenatal screening Down’s syndrome 18-trisomy
  • 相关文献

参考文献4

二级参考文献41

  • 1周林峰,路白杨,贺爱军,王琳琳,霍莹.唐氏综合征产前筛查与诊断的研究[J].中国妇幼保健,2005,20(14):1728-1729. 被引量:47
  • 2侯红瑛,李小毛,滕奔琦,尹玉竹,许成芳,易翠兴.妊娠中晚期羊水细胞核型分析[J].中国优生与遗传杂志,2006,14(8):42-44. 被引量:34
  • 3周玉春,王华,黄定梅,彭向京,贾政军,禹红,田艾军,雷花香.1034例羊水细胞染色体核型分析[J].中华围产医学杂志,2006,9(6):421-423. 被引量:31
  • 4郑辉,骆连妹,陈建勇,袁红梅,李健雄.唐氏综合症孕中期母血筛查及羊水诊断分析[J].中国热带医学,2007,7(1):91-92. 被引量:18
  • 5Herffner LJ.Advanced maternal age-bow old is too old[J] ? N Engl J Med,2004,351:1927.
  • 6陆国辉 陈天健 黄尚志 等.产前诊断及其国内应用的分析.中国优生与遗传杂志,2003,:1-1.
  • 7陆国辉主编.产前遗传学诊断[M]第1版.广州:广东科技出版社,2002.164.
  • 8Wald NJ,et al.Serum screening for Down′s syndrome between 8 and 14 weeks of pregnancy[J].Br.J Obstet Gynecol,1996,103:407.
  • 9Haddw JE,Palomaki GE,Knight GT et al.Prenatal screening for Down′s Syndrome with use of maternal serum markers[J].N Engl J Med,1992,327(9):588.
  • 10Dommergues M,Audibert F,Benaltar C,et al.Is routine amniocentesis for advanced maternal age still indicated[J] ? Fetal Diagn Ther,2001,16:372.

共引文献101

同被引文献32

  • 1王丹,刘丽,宋朝晖,董佳.3657例孕中期唐氏筛查及产前诊断的临床价值分析[J].中国产前诊断杂志(电子版),2010,2(3):17-20. 被引量:17
  • 2李主.医学遗传学[M].2版.重庆:重庆大学出版社,2006.
  • 3Van Gameren-Oosterom HBM, Fekkes M, et al. Problem behavior of individuals with Down syndrome, assessed in a nationwide cohort at late-adolescence[ J]. J of Pediatr,2013,163 (5) : 1396-1401.
  • 4Spencer K, Khalil A, et al. First trimester maternal serum alpha- fetoprotein is not raised in pregnancies with open spina bifida [ J ]. Prenatal Diagnosis,2014,34 (2) : 168-171.
  • 5AcoG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities [ J ]. Obstet Gyneco1,2007,109 ( 1 ) :217-227.
  • 6Van Gameren-Oosterom HBM,Fekkes M,et al.Problem behavior of individuals with Down syndrome,assessed in a nationwide cohort at late-adolescence[J].J of Pediatr,2013,163(5):1396-1401.
  • 7Spencer K,Khalil A,et al.First trimester maternal serum alphafetoprotein is not raised in pregnancies with open spina bifida[J].Prenatal Diagnosis,2014,34(2):168-171.
  • 8Angelova L,Gadancheva V,Konstantinova D,et al.Maternal biochemical screening:an approach for genetic prevention.part2.Sequential approach with integrated risk assessment[J].Akush Ginekol(Sofiia),2013,52(5):14-18.
  • 9Demirhan O,Pazarbasi A,Guzel AI.The reliability of maternal serum triple test in prenatal diagnosis of fetal chromosomal abnormalities of pregnant Turkish women[J].Genet Test Mol Biomarkers,2011,15(10):701-707.
  • 10Demirhan O,Pazarbasi A,Guzel AI,et al.The reliabitity of maternal serum triple test in prenatal diagnosis of fetal chromosomal abnormalities pregnant Turkiis women[J].Genet Test Mol Bioma,2011,15(10):701-707.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部